| Financial Year |
March 31 2023 |
| Monetary Funds |
2,867,531,644.74 |
| Held-for-trading Financial Assets |
393,755,108.65 |
| Notes Receivable |
102,317,926.73 |
| Accounts Receivable |
1,091,854,732.16 |
| Advances to Suppliers |
793,416,702.03 |
| Other Receivables |
287,510,282.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,462,544,089.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,540,187.78 |
| Other Current Assets |
139,987,580.16 |
| Total Current Assets |
11,140,458,253.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,889,571.11 |
| Long-term Equity Investment |
322,368,836.59 |
| Investment Properties |
64,820,201.89 |
| Fixed Assetes |
4,851,825,784.68 |
| Under-construction Projects |
415,360,431.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
939,709,957.85 |
| R&D expenses |
-- |
| Goodwill |
157,486,295.49 |
| Long-Term Deferred and Prepaid Expenses |
28,201,701.67 |
| Deferred Income Tax Assets |
181,107,541.89 |
| Other Non-Current Assets |
59,879,848.17 |
| Sub-Total of Non-Current Assets |
7,123,442,075.26 |
| Total Assets |
18,263,900,329.20 |
| Short-Term Loans |
6,760,560,912.34 |
| Trading Financial liabilities |
1,902,600.00 |
| Notes Payable |
62,199,979.26 |
| Accounts Payable |
1,143,501,523.13 |
| Accounts Received In Advance |
10,439,802.87 |
| Employee Compensation Payable |
78,681,063.33 |
| Taxes Payable |
75,227,367.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
248,116,119.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
190,277,750.21 |
| Other Current Liabilities |
145,667,058.56 |
| Sub-Total of Current Liabilities |
9,974,087,849.97 |
| Long-term Loans |
1,213,398,640.29 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
224,367,138.45 |
| Special Payable |
-- |
| Estimatied Liabilities |
218,082.48 |
| Deferred Income Tax Liabilities |
21,141,748.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,571,437,879.12 |
| Total Liabilities |
11,545,525,729.09 |
| Paid-In Capital(Or Share Stock) |
1,700,681,355.00 |
| Capital Surplus |
2,740,826,583.55 |
| Surplus Reserve |
302,737,887.79 |
| LESS:Treasury Stock |
100,048,630.86 |
| Undistributed Profits |
1,695,558,913.23 |
| Minority Stockholder's Interest |
482,901,986.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,235,472,613.28 |
| Owner's Equity（Stockholder's Equity） |
6,718,374,600.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,263,900,329.20 |
